Cargando…

The contribution of observational studies in supporting the WHO ‘treat all’ recommendation for HIV/AIDS

In 2015, the World Health Organization (WHO) recommended that all people living with HIV (PLWH) should start antiretroviral therapy (ART) irrespective of clinical or immune status. This recommendation followed almost 20 years of research into the clinical and population-level benefits and risks of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ford, Nathan, Penazzato, Martina, Vitoria, Marco, Doherty, Meg, Davies, Mary-Ann, Zaniewski, Elizabeth, Tymejczyk, Olga, Egger, Matthias, Nash, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mediscript Ltd 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248853/ https://www.ncbi.nlm.nih.gov/pubmed/30515308

Ejemplares similares

Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat All
por: Ford, Nathan, et al.
Publicado: (2018)

IeDEA–WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development
por: Zaniewski, Elizabeth, et al.
Publicado: (2018)

WHO guidance to support HIV care models during the Covid-19 era
por: Ford, Nathan, et al.
Publicado: (2021)

Changes in rapid HIV treatment initiation after national “treat all” policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis
por: Tymejczyk, Olga, et al.
Publicado: (2019)

Managing Advanced HIV Disease in a Public Health Approach
por: Ford, Nathan, et al.
Publicado: (2018)

Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis
por: Brazier, Ellen, et al.
Publicado: (2021)

Getting to zero HIV deaths: progress, challenges and ways forward
por: Ford, Nathan, et al.
Publicado: (2013)

HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries
por: Tymejczyk, Olga, et al.
Publicado: (2018)

Mathematical modelling to inform ‘treat all’ implementation in sub-Saharan Africa: a scoping review
por: Kimmel, April D, et al.
Publicado: (2018)

Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis
por: Kanters, Steve, et al.
Publicado: (2020)

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
por: Ford, Nathan, et al.
Publicado: (2020)

Implementing an Indeterminate Range for More Accurate Early Infant Diagnosis
por: Vojnov, Lara, et al.
Publicado: (2019)

When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank
por: Vitoria, Marco, et al.
Publicado: (2017)

Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis
por: Shubber, Zara, et al.
Publicado: (2016)

Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations
por: Doherty, Kathleen, et al.
Publicado: (2014)

Comparative Efficacy of Lamivudine and Emtricitabine: A Systematic Review and Meta-Analysis of Randomized Trials
por: Ford, Nathan, et al.
Publicado: (2013)

Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmes
por: Haas, Andreas D, et al.
Publicado: (2018)

Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?
por: Vitoria, Marco, et al.
Publicado: (2016)

Future directions for HIV service delivery research: Research gaps identified through WHO guideline development
por: Ford, Nathan, et al.
Publicado: (2021)

Gender, HIV-Related Stigma, and Health-Related Quality of Life Among Adults Enrolling in HIV Care in Tanzania
por: Parcesepe, Angela M., et al.
Publicado: (2019)

Setting Global Research Priorities in Pediatric and Adolescent HIV Using the Child Health and Nutrition Research Initiative (CHNRI) Methodology
por: Irvine, Cadi, et al.
Publicado: (2018)

Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease
por: Frigati, Lisa, et al.
Publicado: (2018)

A Global Research Agenda for Pediatric HIV
por: Penazzato, Martina, et al.
Publicado: (2018)

CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis
por: Ford, Nathan, et al.
Publicado: (2018)

Emergency committee recommendations on mpox – what’s next?
por: Lewis, Rosamund F, et al.
Publicado: (2023)

Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration
por: Johnson, Leigh F., et al.
Publicado: (2019)

Benefits and risks of rapid initiation of antiretroviral therapy
por: Ford, Nathan, et al.
Publicado: (2018)

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey
por: Brazier, Ellen, et al.
Publicado: (2019)

International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012–2019
por: Chammartin, Frédérique, et al.
Publicado: (2020)

Paediatric HIV: we are not done yet!
por: Penazzato, Martina
Publicado: (2020)

Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19
por: Bertagnolio, Silvia, et al.
Publicado: (2022)

Use of indirect evidence from HIV self-testing to inform the WHO hepatitis C self-testing recommendation
por: Fonner, Virginia A, et al.
Publicado: (2023)

Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV
por: Waalewijn, Hylke, et al.
Publicado: (2019)

Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
por: Walsh, Jennifer, et al.
Publicado: (2022)

Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa
por: Zaniewski, Elizabeth, et al.
Publicado: (2020)

Optimizing drugs to reach treatment targets for children and adolescents living with HIV
por: Penazzato, Martina, et al.
Publicado: (2015)

Impact of SMS/GPRS Printers in Reducing Time to Early Infant Diagnosis Compared With Routine Result Reporting: A Systematic Review and Meta-Analysis
por: Vojnov, Lara, et al.
Publicado: (2017)

Ending AIDS deaths requires improvements in clinical care for people with advanced HIV disease who are seriously ill
por: Burke, Rachael M, et al.
Publicado: (2023)

Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations
por: Hanekom, Willem A, et al.
Publicado: (2008)

Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review
por: Wedderburn, Catherine J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nmmjkjaq34i84viiuho5e81egg